Compounding Pharmacy · Houston, TX · 503A

ReviveRX Review

ReviveRX is a 503A mail-order compounding pharmacy in Houston, Texas (3831 Golf Dr., 77018) founded in 2016 with compounding operations launched in 2018. Ships to 44 states plus Puerto Rico; provider-portal model, no insurance billing. Advertises 'Weight Loss' and 'Peptide & Longevity' among its compounded-medication categories alongside hormone, sexual wellness, and dermatology preparations. Self-attests FDA-registered vendor procurement, USP-compliant sterile/non-sterile clean rooms, and a 'successful FDA inspection,' but does NOT display LegitScript or PCAB accreditation badges. FDA issued it a warning letter in September 2025 over sterile drugs prepared under insanitary conditions and a new Form 483 in March 2026, and it recalled compounded tirzepatide in 2023 and 2024. Specific GLP-1 drug names are gated behind provider-portal login.

ReviveRX's April 2024 Class I recall involved vials labeled as tirzepatide that contained testosterone cypionate, and FDA's September 2025 warning letter cited sterile drugs prepared under insanitary conditions. WeightCare and Amble are among the programs that list it, and our impurities and immunogenicity review explains why compounding quality matters for injectable GLP-1s.

6 FDA, state or legal actions on record. Most recent: FDA Form 483 (Mar 27, 2026) — see the full record below.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

503AState pharmacy license (self-attested)USP-compliant clean rooms (self-attested)
Location: Houston, TX
Website: reviverx.com
States licensed: 45
6.0/10
★★★☆☆3/5

Editorial score out of 10 · methodology

Regulatory Actions

Class II recall of 45 vials of compounded tirzepatide for subpotency.
FDA Untitled Letter issued to Revive RX LLC.
Class I recall of 751 vials of compounded tirzepatide 10 mg/0.5 mL: product labeled as tirzepatide contained testosterone cypionate (label mix-up).
FDA Form 483 issued to Revive RX LLC, Houston, TX.
FDA Warning Letter (MARCS-CMS 709509) to Revive Rx LLC dba Revive Rx Pharmacy, Houston, TX, after a Jan 27-Feb 7, 2025 inspection: drugs intended to be sterile were prepared under insanitary conditions.
FDA Form 483 issued to Revive RX LLC after a follow-up inspection.

Telehealth Providers Sourcing From This Pharmacy

These telehealth brands are reported to fulfill some or all compounded GLP-1 prescriptions through ReviveRX. Sourcing arrangements can change over time.

7.8/ 10

NP2GO

Best for: transparent per-dose pricing with pay-as-you-go or membership options from a nurse-practitioner-led practice

★★★★☆3.9/5

Editorial score · methodology

$150/mosemaglutide
rises with dose
$250/motirzepatide
rises with dose
SemaglutideTirzepatide
7.5/ 10

Amble

Best for: flat-price compounded GLP-1 with free shipping and discounts for 3- or 6-month plans

★★★★☆3.8/5

Editorial score · methodology

$179/mosemaglutide
after intro offer
$329/motirzepatide
after intro offer
SemaglutideTirzepatide
7.4/ 10

WeightCare

Best for: patients who want PCAB-sourced compounded GLP-1s with discounts for prepaying 3-12 months

★★★★☆3.7/5

Editorial score · methodology

$399/mosemaglutide
$299/motirzepatide
SemaglutideTirzepatideFDA Warning
6.3/ 10

Ways2Well

Best for: wellness-focused patients wanting GLP-1 within a lab-based membership program

★★★☆☆3.2/5

Editorial score · methodology

5.5/ 10

Zealthy

Best for: not currently recommended, and listed for transparency and reader awareness only

★★★☆☆2.8/5

Editorial score · methodology

$286/mosemaglutide
starting dose
$351/motirzepatide
starting dose
SemaglutideTirzepatideFDA Warning

Top-Rated GLP-1 Partners

Not sourced from ReviveRX — these are our highest-scored vetted GLP-1 telehealth partners, if you'd rather start with a provider we've walked through end to end.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

No insurance needed · HSA/FSA eligible · vetted by our editors

7.7

Ro

FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

Starting price: $149/mo (+ required membership)

Get started →Read review Ro →
8.3

Collective

The lowest flat medication price if you can absorb an annual membership fee

Starting price: $59/mo (+ required membership)

Get started →Read review Collective →
8.3

CoreAge Rx

Lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

Starting price: $79/mo (starting price)

Get started →Read review CoreAge Rx →
7.8

Embody

Low flat-rate compounded GLP-1 pricing at every dose

Starting price: $79/mo (sale price)

Get started →Read review Embody →

Certifications & Compliance

All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.

State pharmacy license (self-attested)
Licensed by the pharmacy's home state board of pharmacy. All US pharmacies must hold a state license at minimum.
503A
Traditional patient-specific compounding pharmacy under Section 503A — compounds individual prescriptions and is regulated primarily by its state board of pharmacy.
USP-compliant clean rooms (self-attested)
United States Pharmacopeia compounding standards (USP <795> non-sterile, <797> sterile, <800> hazardous drugs) — the quality chapters state boards enforce for compounded preparations.

Drugs Produced

Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].

Semaglutide
Compounded semaglutide produced
Tirzepatide
Compounded tirzepatide produced

States Licensed (45)

AKAZCOCTDEGAHIIDILINIAKSLAMEMDMAMIMNMSMOMTNENVNHNJNMNYNCNDOHOKORPAPRRISDTNTXUTVTVAWAWVWIWY

What Our Score Weighs

Accreditation
No PCAB accreditation on record
Regulatory record
6 documented actions
State licensure
45 states
GLP-1 compounding
Semaglutide and tirzepatide
Track record
Founding year not published

The 6.0/10 above is our editorial judgment across these five factors, including how serious any regulatory action was. It is not an average of them. See our methodology for details.

Medium confidence · Pharmacy details last verified November 2026 · How we verify provider data

Frequently Asked Questions

ReviveRX is a 503A compounding pharmacy based in Houston, TX. It operates under state board of pharmacy licensure. Note: our records show 6 documented regulatory action(s) — see the Regulatory Actions section below.
ReviveRX is headquartered in Houston, TX. The pharmacy is licensed to ship to 45 US states.
ReviveRX produces compounded semaglutide and compounded tirzepatide in addition to other compounded preparations. As a 503A pharmacy, it dispenses compounded medications in response to individual patient prescriptions under state board of pharmacy oversight.
503A pharmacies prepare compounded medications for individual patients in response to specific prescriptions and are regulated primarily by state boards of pharmacy under USP <797> sterile compounding standards. 503B outsourcing facilities register directly with the FDA, follow current Good Manufacturing Practices (cGMP), and can produce compounded medications in larger batches without patient-specific prescriptions. 503B facilities are subject to FDA inspection.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources & methodology (as of November 2026)
  1. 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.